Clinical Trials Directory

Trials / Completed

CompletedNCT04546984

Multiple Dose Safety, Tolerability, PK,PD and Food Effect Study of HEC96719 in Healthy Adult Subjects

A Randomized, Double-Blind, Placebo-Controlled Study of Ascending Multiple Doses to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics,and Randomized, Open-label,Crossover, Food Effect Study of HEC96719 in Healthy Chinese Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Sunshine Lake Pharma Co., Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The Safety, Tolerability, Pharmacokinetic, Pharmacodynamics and Food Effect Study of HEC96719 in Healthy Subjects

Conditions

Interventions

TypeNameDescription
DRUGHEC96719Part 2:Mulltiple doses up to 10 days

Timeline

Start date
2020-09-14
Primary completion
2020-12-29
Completion
2020-12-29
First posted
2020-09-14
Last updated
2021-05-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04546984. Inclusion in this directory is not an endorsement.

Multiple Dose Safety, Tolerability, PK,PD and Food Effect Study of HEC96719 in Healthy Adult Subjects (NCT04546984) · Clinical Trials Directory